Last reviewed · How we verify
reference drugs
At a glance
| Generic name | reference drugs |
|---|---|
| Sponsor | Pfizer |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Procedural Framing and Epidural Steroid Injection Outcomes (NA)
- Food as Medicine Study (NA)
- The Impact of Music Medicine on Preterm Brain Development and Behavior (NA)
- Human Bioequivalence Study of Liposomal Amphotericin B for Injection (NA)
- Bioequivalence Study of Sacubitril Alisartan Amlodipine Tablets (PHASE1)
- A Study to Compare the Amount of Two Forms of Tafamidis in the Blood of Healthy Adults Under Fed Conditions (PHASE1)
- Buddhist Awareness Training Program and Qigong Psychosocial Interventions for People With Insomnia (NA)
- Bioequivalence Study of EMPAGLIFLOZIN (25 mg Tablets) vs. JARDIANCE® (25 mg Tablets), in Healthy Research Subjects, Under Fasting Conditions (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- reference drugs CI brief — competitive landscape report
- reference drugs updates RSS · CI watch RSS
- Pfizer portfolio CI